Enhancing the Standardization of the Use of Medical Insurance Restricted Drugs through Strengthened Diagnosis and Treatment Audit and Pharmaceutical Intervention

Wei Yedong, Cui Qianqian, Zan Ying, Si Jigang, Ren Xiaojian

Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (4) : 479-484.

PDF(1091 KB)
PDF(1091 KB)
Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (4) : 479-484. DOI: 10.16153/j.1002-7777.2024-11-0044
Hospital Pharmacy

Enhancing the Standardization of the Use of Medical Insurance Restricted Drugs through Strengthened Diagnosis and Treatment Audit and Pharmaceutical Intervention

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 39(4): 479-484 https://doi.org/10.16153/j.1002-7777.2024-11-0044

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1091 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉